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ABSTRACT 12 
Introduction 13 
Black-British communities are disproportionately burdened by type 2 diabetes (T2D) and its 14 
complications. Tackling these inequalities is a priority for healthcare providers and patients. 15 
Culturally-tailored diabetes education provides long-term benefits superior to standard care but 16 
to date such programmes have only been developed in the USA. The current programme of 17 
research aims to develop the Healthy Eating and Active Lifestyles for Diabetes (HEAL-D) 18 
culturally-tailored T2D self-management programme for Black-British communities; and to 19 
evaluate its delivery, acceptability and the feasibility of conducting a future effectiveness trial 20 
of HEAL-D.  21 
Methods & analysis 22 
Informed by Medical Research Council Complex Interventions guidance this research will 23 
rigorously develop and evaluate the implementation of the HEAL-D intervention to understand 24 
the feasibility of conducting a full-scale effectiveness trial. In Phase 1 the intervention will be 25 
developed. The intervention curriculum will be based on existing evidence-based T2D 26 
guidelines for diet and lifestyle management; co-design methods will be used to foster 27 
community engagement, identify the intervention’s underpinning theory; identify the optimal 28 
structure, format and delivery methods, ascertain adaptations that are needed to ensure cultural 29 
sensitivity, and understand issues of implementation. In Phase 2 the intervention will be 30 
delivered and compared to usual care in a feasibility trial. Process evaluation methods will 31 
evaluate the delivery and acceptability of HEAL-D. The effect size of potential primary 32 
outcomes, such as HbA1c and body weight will be estimated. The feasibility of conducting a 33 
future effectiveness trial will also be evaluated, particularly feasibility of randomisation, 34 
recruitment, retention, and contamination. 35 
Ethics & dissemination 36 
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This study is funded by a National Institute of Health Research Fellowship (CDF-2015-08-37 
006), and approved by NHS Research Ethics Committee (17-LO-1954). Dissemination will be 38 
through national and international conferences, peer-reviewed publications and local and 39 
national clinical diabetes networks. 40 
Trial Registration: this trial is registered with www.clinicaltrials.gov, identifier: 41 
NCT03531177.  42 
 43 
STRENGTHS AND LIMITATIONS OF THIS STUDY 44 
• This study employs rigorous complex intervention methodology to develop and 45 
evaluate a culturally-tailored diabetes self-management intervention.  46 
• Participatory co-design methods are being used to foster stakeholder engagement in 47 
intervention development.  48 
• The COM-B behaviour change framework is being used to identify appropriate 49 
intervention behaviour change techniques.  50 
• Process evaluation measures are being collected to assess the feasibility of evaluating 51 
the intervention in a full-scale trial. 52 
• The feasibility trial is designed to estimate the effect size of the intervention rather than 53 
efficacy, which will be the focus of a future definitive trial.  54 
 55 
Keywords: African, Caribbean, ethnicity, type 2 diabetes, education, self-management, diet, 56 
lifestyle  57 
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INTRODUCTION 58 
Type 2 diabetes (T2D) affects approximately 3 million people in England and consumes around 59 
10% of the National Health Service (NHS) budget, estimated at almost £9 billion in 2011 and 60 
predicted to rise to 17% of the NHS budget by 2035 (1). Diabetes and its associated 61 
complications place an illness burden on patients and carers, which disproportionately affects 62 
those from ethnic minority backgrounds (2). The estimated prevalence of T2D is up to 3 times 63 
higher for Black-British communities compared to White Europeans (3). T2D occurs, on 64 
average, 10 years earlier in Black-British people, the mean age of diagnosis is 48 years and 65 
approximately 25% of patients are under the age of 40 years (4). Furthermore, glycaemic 66 
control is worse at the time of diagnosis, requires greater medical management, and poorer 67 
outcomes are evident (5-7). The reasons for these disparities are not fully understood; while 68 
biological factors are involved, it is understood that a range of behavioural, lifestyle and health 69 
system factors play a role. Tackling these inequalities is a healthcare priority (8, 9). 70 
Individuals of Black-British ethnicity form the second largest ethnic minority population in the 71 
United Kingdom (UK); around 4% of the population self-identify from this ethnic background 72 
(10). Around half of individuals are of Black African ancestry and a third of Black Caribbean 73 
ancestry (10). Growth in the Black-British communities is relatively recent, beginning mainly 74 
in response post-second world war appeals to citizens of the Commonwealth regions to assist 75 
with gaps in its labour market. This prompted a large influx of migrants in the 1950s from the 76 
Caribbean islands, particularly Jamaica. Migration from the African continent has been more 77 
recent, peaking around the 1980s; migrants from African nations currently form the largest 78 
growing ethnic minority group in the UK population (11). In some regions, such as London, 79 
Black-British communities may represent 30-40% of the local population and are therefore a 80 
‘majority-minority’ community. Other demographic patterns are recognised; the age 81 
distribution of the Black African and Black Caribbean communities differs, with a larger 82 
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proportion of Black Caribbeans being aged 65 years and over, while in the Black African 83 
population a greater proportion are children and young adults. High rates of unemployment are 84 
evident, averaging around 12% compared to 4% in the White British population (11).  85 
Poor access to diabetes healthcare is a significant issue for minority ethnic groups (2). In the 86 
UK the NHS provides care to all UK residents that is free at the point of delivery. First-line 87 
diabetes management is situated in primary care and aims to promote patient involvement and 88 
self-management (12), enabling patients to adopt a healthy lifestyle and to manage their 89 
diabetes through support and education (13). To achieve this, UK T2D management guidelines 90 
recommend that all patients attend a structured education course to teach them the principals 91 
of T2D self-management and that this be offered annually from the time of diagnosis (14). 92 
Courses are recommended to use a group structure; typically they use face-to-face delivery by 93 
a diabetes specialist nurse or dietitian, with lay educator co-delivery in some cases (14). 94 
Referral to such courses is audited and incentivised through the Quality Outcomes Framework 95 
(15). Ethnic minority groups report finding it more difficult to access primary care services 96 
(16) and are more likely to report that they have not had the opportunity to attend a diabetes 97 
education course than White populations (17). Specifically, African-Caribbean (AfC) 98 
communities often report a distrust of medical advice and a desire for natural, non-99 
pharmacological therapies (18). Furthermore, healthcare professionals are perceived as lacking 100 
cultural understanding (19) and their advice as lacking cultural relevance (20) or being poorly 101 
adapted to culture and needs (18), despite their intentions; these issues may contribute to the 102 
poorer diabetes outcomes and increased morbidity experienced by AfC patients.  103 
Culturally tailored healthcare is proposed to be one of the main ways in which healthcare 104 
disparities can be addressed (21-23) and is identified as a priority by patients (8). Culturally-105 
tailored diabetes education has demonstrated greater improvements in diabetes control and 106 
knowledge than usual care, and the benefits are maintained long-term (22, 24). Culture is a 107 
6 
 
concept that is notoriously difficult to define but generally within healthcare it is thought of as 108 
‘a set of attitudes, values, beliefs and behaviours shared by a group of people, communicated 109 
from one generation to the next’ (25). In their model for understanding cultural sensitivity in 110 
healthcare, Resnicow et al. (1999) described two dimensions in culture: surface and deep 111 
structures. Tailoring interventions to surface structures involves matching materials and 112 
messages to observable, "superficial" characteristics of a target population e.g. language and 113 
food, familiar to, and preferred by, the target audience. Deep structure involves incorporating 114 
the cultural, social, historical, environmental and psychological forces that influence the target 115 
health behaviours in the proposed target population. Whereas surface structure generally 116 
increases the "receptivity" or "acceptance" of messages, deep structure conveys salience (26). 117 
Culture is ever evolving for any group and it is important to recognise the diversity that exists 118 
within any one ‘cultural group’, which is particularly evident in migrant populations where 119 
second/third generations may have undergone significant acculturation. To date, culturally 120 
tailored interventions for the African diaspora have largely been based in the USA, and may 121 
not translate to UK healthcare structures or UK AfC communities whose cultural needs may 122 
be different (23).  123 
A two-phase programme of research is proposed in which a culturally-tailored, evidence-based 124 
self-management programme for T2D in African and Caribbean communities, called Healthy 125 
Eating & Active Lifestyles for Diabetes (HEAL-D), is developed, followed by a feasibility 126 
trial. The intervention curriculum will be based on existing evidence-based guidelines for T2D 127 
(14, 27) to enable it to have potential to be embedded into clinical practice; co-design methods 128 
will be used to identify the optimal structure, format and methods of delivery and to ascertain 129 
appropriate adaptations that are needed to ensure cultural sensitivity of the content. The 130 
purpose of this article is to present the protocol for the development and feasibility trial of 131 
HEAL-D.   132 
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PURPOSE & AIMS 133 
The overall aims of this research are to develop a culturally-tailored, evidence-based self-134 
management programme for managing T2D among AfC communities in primary care, called 135 
HEAL-D, and to determine the feasibility of evaluating HEAL-D through a future effectiveness 136 
trial. 137 
The objectives are to: 138 
1. Develop a self-management programme, based on existing evidence-based diet and 139 
lifestyle guidelines, appropriately tailored for AfC patients through co-design methods. 140 
2. Establish the feasibility of conducting an effectiveness trial of HEAL-D, considering 141 
issues such as participation rates and potential effect sizes. 142 
  143 
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METHODS AND ANALYSIS 144 
Guided by the Medical Research Council’s Complex Interventions framework (28) (Figure 1), 145 
two distinct phases of research are proposed: phase 1 is a formative phase in which the HEAL-146 
D intervention will be developed; and phase 2 will evaluate the HEAL-D intervention in a 147 
feasibility trial. Study recruitment began in April 2017; the study duration will be 36 months. 148 
Phase 1 – Development of a culturally-tailored T2D self-management programme  149 
The process for the development of HEAL-D is outlined in Figure 2. Firstly, to ensure its 150 
potential to be embedded into future clinical practice, the HEAL-D curriculum will align with 151 
existing UK management recommendations and guidelines published by the National Institute 152 
of Clinical Excellence and Diabetes UK (14, 27): 153 
Guidelines for diet and lifestyle management of T2D (27): 154 
1. Achieve 5-10% weight loss or weight maintenance in those of healthy weight. 155 
2. Undertake 150 minutes/week of moderate-to-vigorous intensity aerobic physical 156 
activity plus 2 sessions/week of strength training. 157 
3. Balance carbohydrate intakes through portion control and promotion of low 158 
glycaemic index and wholegrain sources. 159 
4. Limit saturated fat intake (<10% of energy intake), replace with mono-unsaturated 160 
fats. 161 
5. Limit salt intake (<6g per day). 162 
6. Consume oily fish at least twice per week. 163 
Guidelines for T2D recommend that self-management structured education is offered to 164 
adults with T2D and/or their family members or carers, with group education as the preferred 165 
option, and that the education programmes are theory-driven, evidence-based and meet the 166 
cultural, linguistic, cognitive and literacy needs of the population (14). 167 
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Drawing on the existing evidence base  168 
Secondly it will draw on key themes reported in published literature relating to methodologies 169 
for adapting health promotion interventions for ethnic minority groups. These have been 170 
evaluated in a number of recent systematic reviews; aside from acknowledging the lack of UK-171 
based studies, these reviews make several recommendations. The powerful influence of social 172 
networks on health beliefs and behaviours should be acknowledged (29), and a focus on 173 
community-level interventions should be taken; delivering care in a social context promotes 174 
engagement and has been shown to be more effective than traditional individual-centred 175 
behavioural approaches (23). Community engagement should be promoted to overcome issues 176 
of deep-rooted, historical distrust of medical advice and settings, to develop and nurture trust 177 
between the researchers and community, and to nurture the strong sense of collectivism and 178 
kinship networks that are evident amongst AfC communities. Participatory methods (e.g. 179 
patient involvement in intervention design, lay-led delivery of interventions) should be 180 
employed as they are highly effective at improving health behaviours and self-efficacy across 181 
a number of conditions (30). Using community gathering places (e.g. faith institutions) as 182 
intervention settings offers the benefit of cultural relevancy and may reach populations who 183 
would not normally access self-management education (31). 184 
Identifying the intervention’s theoretical basis 185 
Behavioural interventions should have a theoretical under-pinning (28, 32) so that the changes 186 
that are expected, and how these will be achieved, can be predicted from consideration of 187 
known behaviour change techniques. While there have been a number of interventions tailored 188 
to support diet and lifestyle behaviour change in AfC communities (33), their theoretical 189 
underpinning has rarely been drawn out or clearly presented. The theoretical underpinning of 190 
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HEAL-D will be developed through a combination of key themes from the published literature 191 
and new primary research.  192 
In the literature collectivism and the importance of social interaction for people of AfC ancestry 193 
is well reported (29), and the provision of a social support group, or inclusion of a family 194 
member, has been shown to be particularly effective in lifestyle interventions in African-195 
American communities (34, 35). These findings suggest social learning theory, which focuses 196 
on promoting behaviour change through social interaction, role modelling and social 197 
comparison, may be a relevant behaviour change theory for our intervention. Notably, much of 198 
literature that identifies the drivers of health behaviours in AfC communities and may, 199 
therefore, inform the theoretical basis of an intervention, comes from the USA and it is not 200 
known to what extent these findings apply to AfC in other regions. One of the reasons we will 201 
use co-design methods will be to understand the relevance of these existing themes to the UK 202 
context and enable us to identify themes that are important to Black-British communities.  203 
Co-designing the intervention through participatory methods 204 
HEAL-D will use participatory co-design methods to engage patients, healthcare providers and 205 
community leaders (e.g. church leaders, community group leads) in focus groups, interviews 206 
and workshops to achieve the following: 207 
1. Foster community engagement. 208 
2. Identify the theoretical under-pinning of HEAL-D and its mechanisms of action. 209 
3. Identify appropriate cultural adaptations for the intervention. 210 
4. Understand issues of intervention implementation.  211 
Focus groups and interviews 212 
Focus groups, 8-10 groups of 6-8 participants, will be conducted with patients with T2D of 213 
AfC ethnicity, recruited through local churches, mosques and community groups, as well as 214 
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through GP practices in London. The focus groups will be conducted in local accessible 215 
community venues e.g. church hall, library, community centre. Patients will be purposively 216 
sampled to get a spread of socio-economic position, generational status and ancestral origins, 217 
as principal factors impacting on health status, healthcare access and cultural behaviours in 218 
these groups (36-38). Separate focus groups will be conducted with men and women, and 219 
patients of direct African versus Caribbean ancestry, as they report different cultural 220 
barriers/facilitators to lifestyle change (36, 37). A topic guide (Table 1) based on themes 221 
identified in the literature, will be used to steer discussions and ensure coverage of key themes 222 
whilst encouraging free discussion of opinion/perspective. Focus groups have been selected to 223 
enable us to understand normative needs, as suited to the development of a community 224 
intervention. 225 
Semi-structured interviews will be conducted with 8-10 healthcare providers, including general 226 
practitioners, practice nurses, diabetes specialist nurses, diabetes specialist dietitians and 227 
commissioners. The interviews will cover issues relating to healthcare needs and engagement 228 
of AfC patients, experiences of delivering healthcare to AfC patients, and barriers and 229 
facilitators to working in partnership with community groups to deliver care for AfC 230 
communities (Table 1). Interviews have been selected for this part of the study to enable us to 231 
gather a full range of experiences and therefore optimise implementation. 232 
Community leaders representing faith and non-faith institutions (n=4-6) will be invited to 233 
participate in semi-structured interviews. Leaders will be identified initially through existing 234 
networks e.g. Diabetes UK Community Champions initiative. Word-of-mouth and ‘snow-235 
balling’ techniques that are highly effective within these communities, will be used to recruit a 236 
wider network. The interviews will cover issues relating to the role of community networks in 237 
promoting health of AfC communities, sustaining health amongst community members, and 238 
opportunities for greater impact (Table 1). 239 
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Analysis 240 
The focus groups and interviews will be digitally recorded and transcribed verbatim. The data 241 
will be analysed using the framework approach in NVivo (QSR International), theoretically 242 
driven by socio-ecological theory to identify themes relating to issues at the individual, family, 243 
community and healthcare delivery levels and how these influence self-efficacy and behaviour 244 
change. Our analysis will identify priority behaviours of focus for the intervention, key barriers 245 
and facilitators to behaviour change and healthcare engagement, favoured settings, and a 246 
rudimentary draft of the cultural adaptations. Deviant case analysis, that is consideration of 247 
cases that do not fit the general picture, will be undertaken, though our primary interest is in 248 
the commonalities as this is a community level intervention. Primary coding and development 249 
of a coding scheme will be carried out by a single researcher; a second researcher will 250 
independently use this coding scheme to code 20% of the data for cross-comparison, to improve 251 
dependability. This will provide methodological rigour required for confidence in the analysis 252 
of the qualitative data. The themes will be fed-back and discussed with a Service User Group 253 
(SUG), which will consist of representatives of patients, healthcare providers, and community 254 
leaders. The SUG will be set up to inform and guide each stage of the research plan and will 255 
be a forum through which the research team can seek the opinion of key stakeholders, in this 256 
case particularly relating to interpretation of the qualitative data and to ensure trustworthiness 257 
of conceptualisations. The SUG will also review research documents, such as patient 258 
information sheets and questionnaires, and provide feedback on their content and suitability 259 
for the communities of focus. 260 
We will divide our data into behavioural ‘barriers’ and ‘facilitators’ where possible. To 261 
ascertain appropriate behaviour change techniques for our intervention (32) we will map our 262 
analysis onto the Capability-Opportunity-Motivation-Behaviour (COM-B) framework from 263 
the Behaviour Change Wheel (39) (Figure 3), and thence in each case consider the outcome 264 
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behaviours that our intervention will aim to achieve, a worked example is shown in Figure 4. 265 
We will use the COM-B framework to identify appropriate functions of our intervention to 266 
optimise facilitators and overcome barriers to achievement of planned outcomes, e.g. 267 
‘education’ for capability barriers, ‘modelling’ for opportunity and motivation barriers. Finally, 268 
we will select specific behaviour change techniques e.g. education, goal setting, that focus on 269 
the specific functions we have identified. We will also look to identify other themes that arise 270 
from the data, which might not map clearly onto the COM-B framework (e.g. contextual 271 
themes relating to the health system) but which may inform our intervention theory as well as 272 
help us to understand issues of implementation (e.g. favoured settings and timings). Through 273 
this analysis we will identify our intervention theory that we will draw on for the next stage of 274 
the study, as documented through a logic diagram. 275 
Stakeholder co-design workshops 276 
Following evaluation of the focus groups and interviews our stakeholders, 12-15 patients, 277 
healthcare providers, commissioners and community leaders, will be invited to participate in a 278 
series of 2-3 half-day workshops, held in community locations. The workshops will seek to 279 
gain stakeholder involvement in developing the details of the interventions. This will include 280 
determining the setting, the media channels, structure and delivery, as well as steering the 281 
research team to understand and respond to literacy and numeracy needs. The workshops will 282 
endeavour to reach a consensus opinion from attendees but where stakeholders have different 283 
needs and a consensus cannot be reached the research team will consult with the SUG to make 284 
decisions on the way forward and consider where there is scope for the intervention to be 285 
structured to meet these different needs e.g. delivery in a range of settings. In the first workshop 286 
the research team will feed back the findings of the focus groups and interviews; anonymised 287 
interview extracts will be presented to illustrate the key themes and issues that were identified. 288 
The stakeholders will be asked to discuss the themes and behavioural targets in small groups, 289 
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using directed tasks/questions to facilitate the discussions. Following the small group 290 
discussions the researchers will facilitate discussion as a whole to clarify/confirm 291 
interpretation; open discussion/debate will be encouraged to examine the themes in depth and 292 
for all stakeholders to agree a mutual understanding.  293 
In the second workshop elements of the proposed intervention will be presented for comment, 294 
refining and development. Using scenarios, the stakeholders will be asked to brainstorm, in 295 
small groups, key issues relating to the scenarios. For example, the moderator will present 296 
scenarios relating to the intervention setting and the attendees will be asked to discuss and 297 
identify the pros and cons of each, and then feedback their discussions to the other attendees. 298 
The attendees will be asked to review existing educational/support materials e.g. leaflets and 299 
videos and provide feedback on, for example, language/phrasing, content, pitch and 300 
understanding. The research team will then facilitate cross-discussion between groups to 301 
develop the conclusions and a consensus. 302 
In the final workshop draft intervention materials, developed from workshops 1 and 2, will be 303 
presented. For example, media channels that could be used to promote behaviour change such 304 
as testimonials, story-telling, and cooking demonstrations. The stakeholders will be divided 305 
into small groups to discuss and provide feedback on the acceptability of the components of 306 
the intervention and identify potential barriers to engagement. Following the small group 307 
discussions the researchers will facilitate feedback and encourage discussion as a whole to 308 
clarify/confirm the researcher’s interpretation. The intervention template may be further 309 
refined, and will be developed into the detailed programme. 310 
 311 
Phase 2 – Evaluation of HEAL-D; a culturally-tailored T2D self-management 312 
programme for African and Caribbean communities 313 
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In phase 2 a feasibility study, with an embedded process evaluation, will be conducted to 314 
address the following objectives: 315 
1. Evaluate the HEAL-D intervention, particularly its theoretical under-pinning, 316 
acceptability, fidelity, issues of implementation and sustainability. 317 
2. Evaluate the feasibility of trial procedures, considering issues such as rates of 318 
recruitment, retention, completion and contamination.  319 
3. Estimate the effect size of potential trial outcomes including HbA1c, weight, waist 320 
circumference, blood pressure, dietary intake, physical activity levels, diabetes 321 
knowledge, and quality of life, to inform an effectiveness trial. 322 
Study Design 323 
The feasibility study will use a randomised controlled design (RCT), with individual patients 324 
as the unit of randomisation, evaluating HEAL-D against usual care. In addition, there will be 325 
a cohort of phase 1 co-design patients who will be allocated to the intervention arm (not 326 
randomised) because their involvement in the intervention design phase would contaminate the 327 
control arm. These patients will be included in the feasibility study to enable us to evaluate the 328 
impact of former involvement on intervention engagement, acceptability and ownership.  329 
Participants 330 
Participants will principally be recruited from General Practice in the London Boroughs of 331 
Lambeth and Southwark through screening of referrals for structured education and letters of 332 
invitation to patients with established T2D. In addition, participants from the phase 1 co-design 333 
study will be invited to participate, and self-referral methods will also be used, for example 334 
posters and advertisements in community locations.   335 
Patients with diagnosed T2D who are of African or Caribbean ethnicity and with capacity to 336 
provide fully informed consent to participation in research will be eligible to participate in the 337 
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trial. Ethnicity will be self-declared using the standard NHS ethnicity categorisation 338 
questionnaire. Patients who are unable to communicate in English and patients with complex 339 
therapeutic dietary needs may be ineligible to participate if their individual needs are deemed 340 
incompatible with the aims of the intervention. This is because the intervention will provide 341 
general diet and lifestyle advice for the self-management of T2D in a group setting; in cases of 342 
patients with certain comorbidities e.g. advanced renal disease, the intervention may be 343 
inappropriate for the individual, and the group nature of the intervention will prevent their 344 
individual needs from being addressed. 345 
A pragmatic sample size of 120 patients is anticipated to be sufficient to evaluate the 346 
programme, allowing for 20% drop-out/non-completion; 80 patients will be randomised, 40 in 347 
each arm, and a further cohort of patients (n=40) from phase 1 will be allocated to the 348 
intervention arm without randomisation. As this is a feasibility trial it will not be powered to 349 
detect statistically significant intervention effects. A primary objective of the study is to 350 
provide estimates of key parameters such as potential effect sizes, recruitment and retention 351 
rates of the trial and participation rates of the programme, to enable the optimal design of a 352 
full-scale trial to be determined. 353 
Intervention and control arms 354 
Participants in the control arm will continue with usual care deemed appropriate and delivered 355 
by their primary care team, which may include referral to group structured education and/or 356 
one-to-one consultations with healthcare professionals. 357 
Participants in the intervention arm will be offered the HEAL-D programme, which will deliver 358 
a curriculum of culturally-tailored, evidence-based diet and physical activity education and 359 
behavior change in a group setting. In line with clinical guidelines, the programme will be 360 
delivered by trained educators (external to the research team); favoured educators (e.g. lay 361 
educators versus healthcare professionals) will be identified in the co-design process. The 362 
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details of each session, particularly the behavior change techniques and corresponding 363 
activities/materials will be identified through the co-design work. 364 
The proposed curriculum will map to evidence-based guidelines, and will be as follows: 365 
1. An introduction to T2D self-management principles. 366 
2. Physical activity in T2D management. 367 
3. Carbohydrates & portion sizes. 368 
4. Weight management for T2D. 369 
5. Managing cardiovascular health. 370 
In line with clinical guidelines for diabetes structured education, the education sessions will be 371 
delivered through educator-led interactive discussion, however support materials will be 372 
provided to reinforce the learning, detailing evidence-based diet and physical activity guidance, 373 
which is culturally tailored for the African and Caribbean communities.  374 
Data Collection 375 
We will use a mixed methods approach, collecting a range of quantitative and qualitative data, 376 
to evaluate the intervention and the feasibility of trial procedures.  377 
Estimating the effect of the intervention on potential trial outcomes 378 
Participants will attend a baseline and post-intervention follow-up assessment visit, conducted 379 
by a research technician, at 26-32 weeks to collect the following potential trial outcomes and 380 
estimate effect sizes: 381 
Biomedical outcomes: a 5ml venous blood sample will be taken for analysis of HbA1c and 382 
total- HDL- & LDL-cholesterol, triglycerides. Systolic and diastolic blood pressure will be 383 
measured using an automated sphygmomanometer. 384 
Anthropometric outcomes: body weight will be measured using digital scales, with the patient 385 
wearing light clothing (without shoes); height will be measured, using a stadiometer, without 386 
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shoes; body mass index (BMI) will be calculated as [weight kg/height m2]. Waist 387 
circumference will be measured with the patient wearing only light clothing, at the mid-point 388 
between the lowest rib and the iliac crest.  389 
Diet & physical activity behaviour outcomes: dietary intake will be assessed through 390 
completion of a 24-hour diet recall, using the structured multiple pass interview method, and 391 
physical activity through 3-day Actiwatch accelerometer assessment and completion of the 392 
International Physical Activity Questionnaire (IPAQ). 393 
The following validated self-complete questionnaires will be administered to assess: diabetes 394 
knowledge (Short Diabetes Knowledge Instrument (40)); diabetes and diet knowledge and 395 
competence (Perceived Diabetes & Dietary Competence (37)); empowerment (Diabetes 396 
Empowerment Scale- Short Form (41)); social support (Multidimensional Scale of Perceived 397 
Social Support (42)); diabetes distress (PAID-5 (43)) and quality of life (EQ-5D-3L (44)). 398 
 399 
Statistical analysis: Given that this is a feasibility study with a small sample size, descriptive 400 
statistics will be used (Chi-Square test, Fisher’s exact test). Differences between the groups in 401 
all outcomes will be estimated with 95% confidence intervals. The descriptive data will provide 402 
stable estimates of the variability of continuous outcomes by group, and provide estimates of 403 
differences between the groups in means and proportions for the key outcomes. The standard 404 
deviations of the mean change in HbA1c will be estimated by arms and used to derive the 405 
sample size calculation for a subsequent trial. 406 
 407 
Evaluation of the HEAL-D intervention 408 
Process evaluation is an essential part of testing complex interventions (45) and will be used in 409 
our feasibility trial to evaluate the HEAL-D intervention and the feasibility of trial procedures. 410 
Our process evaluation aims to achieve the following: 411 
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1. Test the intervention theory and whether the mechanisms of change operationalise as 412 
hypothesised.  413 
2. Understand how the multiple components of the intervention interact. 414 
3. Evaluate contextual factors that influence operationalisation of the intervention’s 415 
theory/mechanisms of change, and any unintended effects of these factors. 416 
4. Evaluate whether the intervention is differentiable from ‘usual practice’. 417 
5. Evaluate implementation of the intervention, particularly ‘reach’ (e.g. who receives the 418 
intervention), ‘dose’ and completion rates, and intervention fidelity (e.g. coverage of 419 
core materials and learning objectives during delivery, and the extent to which the 420 
programme is delivered in accordance with the delivery manual, what adaptations are 421 
undertaken and why). 422 
6. Evaluate acceptability of the intervention to patients, healthcare professionals and 423 
commissioners. 424 
7. Evaluate intervention embedding and sustainability e.g. what are the barriers and 425 
facilitators to the uptake of the intervention in current care pathways.  426 
A range of quantitative and qualitative data will be collected, as detailed in Table 2. Attendance 427 
records, observation checklists, session/programme evaluation forms completed by patients 428 
and records of session activities completed by educators will provide quantitative data and will 429 
be used to evaluate a number of process domains, as indicated in Table 2. Our process 430 
evaluation will mainly focus on qualitative evaluations, with which we will use inductive 431 
reasoning to determine whether the intervention requires further development and adaptation. 432 
Patient interviews and focus groups, and interviews with educators, healthcare professionals 433 
and commissioners, and session observation notes will provide qualitative data for the 434 
evaluation of a number of process domains, as detailed in Table 2.  435 
 436 
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Evaluation of trial procedures  437 
The feasibility of trial procedures will be evaluated, particularly rates and methods of 438 
recruitment, retention, completion, contamination between study arms and the proposed data 439 
collection methods: 440 
Recruitment: several different pathways of recruitment will be implemented e.g. screening of 441 
primary care databases and letters of invitation, face-to-face referral during medical 442 
appointments, self-referral via posters, word-of-mouth referral. We will assess uptake rates 443 
from these different pathways to enable us to identify the most effective methods and assess 444 
the feasibility of recruiting for a full-scale trial.  445 
Retention & completion: we will assess the rate of retention both within the HEAL-D 446 
intervention (i.e. numbers completing each session and the full programme) and the feasibility 447 
trial (i.e. numbers completing baseline and endpoint assessment visits). We will evaluate the 448 
feasibility of randomising and retaining a control arm by assessing drop-out rates and 449 
comparing these between the study arms; we will also interview control arm patients to explore 450 
the acceptability of being assigned to the control arm. 451 
Data collection methods: we will assess the frequency of missing data and any trends in which 452 
data is missing e.g. self-complete questionnaires, blood measures, to assess the feasibility of 453 
our data collection methods. 454 
Contamination: we will interview patients from the control arm to explore issues of 455 
contamination e.g. did their participation in the trial promote change in self-management 456 
behaviours or motivate information-seeking behaviours, did they know anybody in the 457 
intervention arm or discuss the intervention with anybody.  458 
  459 
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PATIENT AND PUBLIC INVOLVEMENT 460 
Service user involvement is intrinsic to this proposed research, which utilises participatory 461 
methods to engage patients and other stakeholders in the intervention design. The protocol 462 
provides extensive detail of how patients will be involved in the design, recruitment, conduct 463 
and dissemination of the research. 464 
ETHICS & DISSEMINATION 465 
The study protocol has been approved by the Fulham: London Research Ethics Committee (17-466 
LO-1954); all participants will provide written consent prior to participation. All data will be 467 
anonymised and data protection protocols followed. 468 
The study findings will be disseminated to the scientific community via conference 469 
presentations and peer-reviewed manuscripts, and to healthcare professionals via national and 470 
local clinical networks. The findings of the study will be communicated to our participants and 471 
local communities via the community networks and figureheads who we will engage in our 472 
participatory methods; we will give presentations at church events and publish a newsletter via 473 
our study website (www.heal-d.co.uk).  474 
DISCUSSION 475 
This paper presents the protocol for the design and feasibility testing of HEAL-D, a culturally-476 
tailored T2D self-management programme for UK African and Caribbean communities. This 477 
study will employ rigorous complex intervention methodology to develop and evaluate the 478 
implementation of a culturally-tailored T2D self-management intervention. The intervention’s 479 
curriculum will be based on existing evidence-based guidelines for diet and lifestyle 480 
management of T2D, participatory co-design methods will be employed to foster community 481 
engagement and partnership. We will use a ‘bottom-up’ approach to identify the cultural 482 
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adaptations of our intervention, and identify its theoretical basis through thematic analysis and 483 
the COM-B behavior change framework. The feasibility study will provide us with key 484 
information about the feasibility of running a full-scale trial of HEAL-D and process evaluation 485 
methods will enable us to understand how and why the intervention is effective or ineffective.  486 
To date there have been no tailored education programmes for Black-British communities. 487 
Indeed it is not known to what extent culturally-tailored care is needed for Black-British 488 
communities as little work has been undertaken with these communities. Our co-design work 489 
is intended to explore the socio-cultural barriers and facilitators to behaviour change and 490 
structure HEAL-D accordingly. We acknowledge that we are likely to find huge diversity 491 
within our Black-British communities and culture will likely be only one of many important 492 
factors that affects their health behaviours. However, our co-design work will provide a more 493 
comprehensive theoretical under-pinning for the content of our programme than that which 494 
currently exists and will provide us with a framework upon which to evaluate the effectiveness 495 
of our programme. This work will provide essential information and evaluation to inform the 496 
design of a future definitive trial. 497 
  498 
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ABBREVIATIONS 499 
AfC  African-Caribbean 500 
COM-B Capability Opportunity Motivation Behaviour 501 
HEAL-D Healthy Eating & Active Lifestyles for Diabetes 502 
MRC  Medical Research Council 503 
NHS  National Health Service 504 
T2D  Type 2 diabetes 505 
 506 
DECLARATIONS 507 
The study protocol has been approved by the Health Research Authority (London Fulham 508 
Research Ethics Committee; 17/LO/1954); all participants will provide written consent prior 509 
to participation. 510 
CONSENT FOR PUBLICATION 511 
Not applicable. 512 
AVAILABILITY OF DATA AND MATERIALS 513 
Not applicable. 514 
COMPETING INTERESTS 515 
The authors declare that they have no competing interests. 516 
FUNDING 517 
24 
 
This report is independent research arising from a Career Development Fellowship (Louise M. 518 
Goff, CDF-2015-08-006) supported by the National Institute for Health Research. The views 519 
expressed in this publication are those of the author(s) and not necessarily those of the NHS, 520 
the National Institute for Health Research or the Department of Health.  521 
AUTHOR CONTRIBUTIONS 522 
All authors have made substantial contributions to this study. LMG, CR and SH were 523 
responsible for the conception and design of the study. LMG, CR, SH and AM developed the 524 
protocol and study approach. LMG drafted the manuscript. All authors read, revised and 525 
approved the final manuscript. LMG is guarantor. 526 
ACKNOWLEDGEMENTS 527 
Not applicable. 528 
 529 
  530 
25 
 
FIGURE LEGENDS 531 
Figure 1. Medical Research Council’s framework for the development and evaluation of 532 
complex interventions.  Reproduced from Craig P. et al. British Medical Journal. 2008; 533 
337:a1655. 534 
Figure 2. Schematic diagram of Phase I: Development of HEAL-D using evidence synthesis 535 
and co-design methodology to design a culturally-tailored self-management programme for 536 
T2D in African and Caribbean communities 537 
Figure 3. The Capability-Opportunity-Motivation (COM-B) Framework and Behaviour 538 
Change Wheel; a framework for developing behavioural interventions. Reproduced from 539 
Michie S., van Stralen M.M. and West R. Implementation Science. 2011; 6:42. 540 
Figure 4. Applying the COM-B behaviour change framework to the development of the 541 
HEAL-D intervention; identifying theory of change. 542 
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Table 1. Topic guides for patient focus groups and stakeholder interviews 
Patient focus groups 
 Knowledge and perceptions of diabetes, and diet and lifestyle advice for managing diabetes. 
 Current practices relating to diabetes self-care, and diet and lifestyle. 
 Health concerns/priorities in relation to diabetes. 
 Motivations and barriers/difficulties relating to diabetes self-care, weight management and diet and lifestyle. 
 Experiences and perceptions of diabetes care/education, and barriers to accessing care. 
 Experiences of behaviour change in relation to diabetes, weight, diet and lifestyle – successes and failures. 
 Role of family/friends/communities in influencing and shaping knowledge and behaviours in relation to diabetes, diet and lifestyle. 
  
Community leader interviews (including religious leaders) 
 Health problems affecting the community and diabetes impact on health within this context. 
 Attitude of the community towards health, medicines, doctors. 
 Role of community leaders in promoting health and community activities. 
 Diabetes health promotion activities within the community. What worked and what didn’t. 
 Barriers and facilitators to positive diabetes behaviours within the community. 
 Advice about engaging the community: Who are the role models; What will engage and help people; How can healthcare & 
community work together. 
  
Healthcare professional interviews  
 Experience of supporting African & Caribbean patients. What are the issues. How could things be improved. What factors make 
successful T2D management likely. 
 Patient beliefs and motivations. 
 Involvement in community activities and experience of working with community leaders and lay educators and suggestions to 
improve partnerships. 
 Difficulties & challenges with offering a tailored lifestyle intervention. 
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Table 2. Mapping of the HEAL-D feasibility study research questions, process evaluation data sources and evaluation methods  
PROCESS EVALUATION DOMAIN  
& RESEARCH QUESTIONS 
DATA SOURCES EVALUATION METHOD 
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TESTING INTERVENTION THEORY & MECHANISMS OF CHANGE  
Are the intervention’s mechanisms of change 
operationalised as hypothesised? 
X X X X X X X    
Qualitative data collected through 
interviews/focus groups with patients and 
educators, and session observation notes will be 
used to evaluate how the theory of the 
intervention operationalises and interacts with 
contextual factors.  
How is the operationalisation of the mechanisms of 
change influenced by contextual factors? 
 X X  X X X    
Does the interaction of the mechanisms of change with 
contextual factors give rise to unintended effects? 
 X X  X X X    
ASSESSING USUAL PRACTICE & CONTAMINATION  
Is HEAL-D differentiable from ‘usual practice’?      X     Interviews will be conducted with patients from 
both arms. Experiences of the intervention and 
control will be explored. With control patients 
issues of contamination and perceptions of ‘usual 
care’ will be discussed. 
Is there contamination in control patients? 
     X     
ASSESSING IMPLEMENTATION   
What is the intervention reach and dose? 
X       X   
Questionnaire data will assess who receives the 
intervention and how representative they are e.g. 
age, gender, ethnicity, working status. 
Attendance records will be used to quantify the 
proportion of patients receiving the full vs part 
intervention. 
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Are the HEAL-D components/sessions delivered with 
fidelity and what is the nature of any adaptions? 
 X X  X      
To assess fidelity and compare intervention 
deliveries and contextual impacts educators will 
complete a record of activities & materials and 
list any resources/activities/discussions that were 
additional to the standardised schedule. These 
will be explored in depth in educator interviews 
which will be conducted at the end of the 
programme delivery. The research team will 
observe HEAL-D delivery to quantitatively 
assess coverage of curriculum, use of supporting 
materials and behaviour change techniques, 
quality of delivery, and participant engagement 
(binary score or a five-point Likert scale). 
Observers will qualitatively document course 
adaptations and general contextual observations. 
Does the delivery of HEAL-D differ between sites, and 
what gives rise to differences? 
 X X  X      
How well are the HEAL-D components/sessions 
delivered? 
 X X        
ASSESSING INTERVENTION ACCEPTABILITY  
Is HEAL-D acceptable to patients, commissioners and 
healthcare professionals? 
 X  X  X X  X X 
Acceptability will be evaluated through a range 
of qualitative and quantitative data. Quantitative 
data will be generated in patient evaluations, 
which will use 10-point scales to assess their 
views on the quality of the programme content, 
structure, format and delivery; the 
sessions/programme will be deemed ‘acceptable’ 
where they score ≥6 points. Interviews/focus 
groups with patients, educators, healthcare 
professionals and commissioners will explore 
acceptability through qualitative data e.g. reasons 
for attendance/non-attendance among patients, 
suggestions for amendments.   
ASSESSING INTERVENTION SUSTAINABILITY  
How likely is the HEAL-D intervention to be 
sustainable and what factors might ensure 
sustainability?         X X 
Qualitative data collected through interviews 
with healthcare professionals and commissioners 
will be used to evaluate barriers & facilitators to 
implementation of HEAL-D into current care 
pathways, and its fit with organisational 
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priorities, and the feasibility of sustained resource 
allocation to the HEAL-D intervention if found to 
be successful. 
HCP, Healthcare professionals
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